- Report
- March 2024
- 200 Pages
Global
From €3670EUR$4,150USD£3,169GBP
- Report
- March 2024
- 249 Pages
Global
€4417EUR$4,995USD£3,814GBP
- Report
- March 2024
- 197 Pages
Global
€4417EUR$4,995USD£3,814GBP
- Report
- February 2024
- 116 Pages
Global
From €4413EUR$4,990USD£3,810GBP
- Training
- February 2024
- 90 Minutes
Global
From €615EUR$695USD£531GBP
- Report
- February 2024
- 16 Pages
Global
- Report
- January 2024
- 310 Pages
Global
From €3095EUR$3,500USD£2,672GBP
- Report
- January 2024
- 250 Pages
Global
€4417EUR$4,995USD£3,814GBP
- Report
- January 2024
- 242 Pages
Global
€4417EUR$4,995USD£3,814GBP
- Report
- January 2024
- 250 Pages
Global
€4417EUR$4,995USD£3,814GBP
- Report
- January 2024
- 200 Pages
Global
From €3670EUR$4,150USD£3,169GBP
- Report
- November 2023
- 366 Pages
Global
€4417EUR$4,995USD£3,814GBP
- Report
- November 2023
- 29 Pages
United States
€2211EUR$2,500USD£1,909GBP
- Report
- October 2023
- 85 Pages
United States
From €4289EUR$4,850USD£3,703GBP
- Report
- September 2023
- 114 Pages
Global
From €2609EUR$2,950USD£2,252GBP
- Report
- September 2023
- 87 Pages
Middle East, Africa
From €2609EUR$2,950USD£2,252GBP
- Report
- September 2023
- 89 Pages
From €2609EUR$2,950USD£2,252GBP
- Report
- September 2023
- 107 Pages
Asia Pacific
From €3051EUR$3,450USD£2,634GBP
- Report
- September 2023
- 112 Pages
Europe
From €3051EUR$3,450USD£2,634GBP
- Report
- September 2023
- 101 Pages
North America
From €2609EUR$2,950USD£2,252GBP

The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more